Compass Therapeutics Inc. at Goldman Sachs Healthcare Conference Transcript
Last night.
Sorry, I'm going to go for this a little.
All right, good morning.
Let's kick off our next session. It's my pleasure to be hosting Office Therapeutics.
And with me is Tom with the company.
Welcome. It's the first time for me to host you at the GF Conference. So welcome and look forward to a very exciting discussion. Before we begin, I'm going to take it off to you for opening remarks.
Sure.
Thank you very much.
Thank you for inviting us to the conference. I'm really excited to be here. So.
Compass Therapeutics is located in Boston. We're a monoclonal antibody discovery and development company in oncology. We currently have four drugs in the clinic, which hopefully we'll talk about today. So our lead asset is a drug called Tavecimib, that's a DLL4 VEGFA bispecific antibody, and we just read out secondary endpoint results from a randomized trial, and we're going
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
